You are here

Medicare

Investors shrug off drug price talks' effects

Axios

Mon, 08/19/24 - 10:09 am

Inflation Reduction Act

Medicare drug price cuts could have limited early impact, but grow with time

BioPharma Dive

Fri, 08/16/24 - 11:26 am

Inflation Reduction Act

Doctors struggle to get Wegovy for older Americans with heart disease

Reuters

Thu, 08/15/24 - 11:41 am

Experts analyze IRA’s effect as the industry awaits negotiated CMS drug prices

BioSpace

Wed, 08/14/24 - 10:44 pm

Inflation Reduction Act

What to watch when Medicare releases first negotiated drug prices

Axios

Wed, 08/14/24 - 11:01 am

Inflation Reduction Act

5 things to know ahead of the Medicare drug price announcement

Beckers Hospital Review

Mon, 08/12/24 - 05:53 pm

Inflation Reduction Act

CMS finalizes notice on Medicare coverage for breakthrough devices

Medtech Dive

Fri, 08/9/24 - 11:27 am

breakthrough devices

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Access is unequal to weight-loss drugs Ozempic and Wegovy: study

Axios

Mon, 08/5/24 - 11:08 am

Ardelyx sues US health department over kidney disease drug

Reuters

Wed, 07/17/24 - 09:10 pm

J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses

Fierce Pharma

Tue, 07/16/24 - 12:00 pm

Inflation Reduction Act

Bristol Myers Squibb

Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling

BioSpace

Mon, 07/8/24 - 11:38 am

Boehringer Ingelheim

Inflation Reduction Act

House committee backs some Medicare cover for obesity drugs

Pharmaphorum

Fri, 06/28/24 - 11:13 am

House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound

Stat

Thu, 06/27/24 - 11:13 am

Amazon Pharmacy expands $5 monthly subscription to Medicare patients

Reuters

Tue, 06/18/24 - 11:35 am

Amazon pharmacy

Senate Finance Committee introduces legislation aimed at fixing drug shortages

The Hill

Fri, 05/3/24 - 11:30 am

J&J, Bristol Myers lose challenges to US drug price negotiation program

Reuters

Mon, 04/29/24 - 10:52 pm

Bristol Myers Squibb

Inflation Reduction Act

About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows

Reuters

Wed, 04/24/24 - 09:59 am

DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea

BioSpace

Thu, 04/11/24 - 11:27 am

False Claims Act

Pages